Pubblicazioni

ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients

2021 - HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION

Presta, Vivianne; Figliuzzi, Ilaria; Citoni, Barbara; Gallo, Giovanna; Battistoni, Allegra; Tocci, Giuliano; Volpe, Massimo

A plea for smoking-free policies in COVID-19 times: cardiovascular prevention as an ally in coronavirus containment

2021 - HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION

Tini, G.; Gallo, G.; Musumeci, B.; Tocci, G.; Volpe, M.

Commentary to angiotensin-converting-enzyme 2 and reninâangiotensin system inhibitors in COVID-19. an update

2021 - HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION

Ferri, C.; Desideri, G.; Del Pinto, R.

Renin-angiotensin system inhibition in cardiovascular patients at the time of COVID19. Much ado for nothing? A statement of activity from the directors of the board and the scientific Directors of the Italian Society of hypertension

2020 - HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION

Iaccarino, G.; Borghi, C.; Cicero, A. F. G.; Ferri, C.; Minuz, P.; Muiesan, M. L.; Mulatero, P.; Mule, G.; Pucci, G.; Salvetti, M.; Savoia, C.; Sechi, L. A.; Volpe, M.; Grassi, G.

Pubblicazioni

ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients

A plea for smoking-free policies in COVID-19 times: cardiovascular prevention as an ally in coronavirus containment

Commentary to angiotensin-converting-enzyme 2 and reninâangiotensin system inhibitors in COVID-19. an update

Renin-angiotensin system inhibition in cardiovascular patients at the time of COVID19. Much ado for nothing? A statement of activity from the directors of the board and the scientific Directors of the Italian Society of hypertension

Commentary to angiotensin-converting-enzyme 2 and reninâangiotensin system inhibitors in COVID-19. an update